nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinalukast—CYSLTR1—Endothelins—PLCB2—prostate cancer	0.0338	0.0341	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GRPR—prostate cancer	0.0237	0.024	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRPR—prostate cancer	0.0212	0.0214	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—PRKCQ—prostate cancer	0.0209	0.0212	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—GRPR—prostate cancer	0.0183	0.0185	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—RLN2—prostate cancer	0.0178	0.018	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GRPR—prostate cancer	0.0157	0.0159	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—MC2R—prostate cancer	0.015	0.0152	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GNRH1—prostate cancer	0.0147	0.0149	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—LPAR1—prostate cancer	0.0143	0.0144	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GRP—prostate cancer	0.0143	0.0144	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—PLCB2—prostate cancer	0.0141	0.0143	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—RLN2—prostate cancer	0.0136	0.0137	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—prostate cancer	0.0132	0.0133	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—MC2R—prostate cancer	0.0129	0.013	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GNG5—prostate cancer	0.0128	0.013	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—LPAR1—prostate cancer	0.0128	0.0129	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—prostate cancer	0.0128	0.0129	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB2—prostate cancer	0.0126	0.0128	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GRPR—prostate cancer	0.0119	0.0121	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—PENK—prostate cancer	0.0115	0.0116	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG5—prostate cancer	0.0115	0.0116	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAP2K1—prostate cancer	0.0114	0.0116	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—ANXA1—prostate cancer	0.0105	0.0106	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—JAK2—prostate cancer	0.0104	0.0105	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—WNT4—prostate cancer	0.0103	0.0104	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—OR51E2—prostate cancer	0.0101	0.0102	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—MC2R—prostate cancer	0.00981	0.00992	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—prostate cancer	0.00976	0.00988	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—LPAR1—prostate cancer	0.00946	0.00956	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GRP—prostate cancer	0.00946	0.00956	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—prostate cancer	0.0094	0.0095	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—OR51E2—prostate cancer	0.00919	0.00929	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—prostate cancer	0.00918	0.00928	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—PRKCQ—prostate cancer	0.00877	0.00887	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—PENK—prostate cancer	0.00874	0.00884	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—RGS17—prostate cancer	0.0086	0.0087	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—SRC—prostate cancer	0.00793	0.00802	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—prostate cancer	0.00784	0.00793	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RGS17—prostate cancer	0.00781	0.0079	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—ITPR1—prostate cancer	0.0078	0.00789	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—RLN2—prostate cancer	0.00767	0.00776	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GNRH1—prostate cancer	0.00744	0.00752	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—LPAR1—prostate cancer	0.0072	0.00728	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GRP—prostate cancer	0.0072	0.00728	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PLXNB1—prostate cancer	0.00701	0.00709	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CX3CL1—prostate cancer	0.00699	0.00707	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—prostate cancer	0.00697	0.00705	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RLN2—prostate cancer	0.00696	0.00704	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—prostate cancer	0.00696	0.00704	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GRPR—prostate cancer	0.00675	0.00683	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GNG5—prostate cancer	0.00647	0.00654	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRB2—prostate cancer	0.00637	0.00644	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PLXNB1—prostate cancer	0.00637	0.00644	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—prostate cancer	0.00636	0.00644	CbGpPWpGaD
Cinalukast—CYSLTR1—prostate gland—prostate cancer	0.00614	0.545	CbGeAlD
Cinalukast—CYSLTR1—Signaling by GPCR—GRPR—prostate cancer	0.00613	0.0062	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—PTHLH—prostate cancer	0.00563	0.0057	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—MC2R—prostate cancer	0.00554	0.00561	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.00546	0.00552	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—OR51E2—prostate cancer	0.00543	0.00549	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—ANXA1—prostate cancer	0.0053	0.00536	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—WNT4—prostate cancer	0.00528	0.00534	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MC2R—prostate cancer	0.00503	0.00509	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BMPR1B—prostate cancer	0.00496	0.00502	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CALCA—prostate cancer	0.00496	0.00502	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PENK—prostate cancer	0.00494	0.005	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—AKT1—prostate cancer	0.00493	0.00498	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL12—prostate cancer	0.00485	0.0049	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RGS17—prostate cancer	0.00462	0.00467	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PENK—prostate cancer	0.00449	0.00454	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—prostate cancer	0.00428	0.00433	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GNRH1—prostate cancer	0.0042	0.00425	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—VIP—prostate cancer	0.0042	0.00425	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—ADRB2—prostate cancer	0.00416	0.0042	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RLN2—prostate cancer	0.00411	0.00416	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GRP—prostate cancer	0.00407	0.00412	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—LPAR1—prostate cancer	0.00407	0.00412	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PLCB2—prostate cancer	0.00403	0.00407	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HSD17B1—prostate cancer	0.00392	0.00397	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CTBP2—prostate cancer	0.00392	0.00397	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.0039	0.00395	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PDE4D—prostate cancer	0.00384	0.00389	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—VIP—prostate cancer	0.00382	0.00386	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GNRH1—prostate cancer	0.00382	0.00386	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLXNB1—prostate cancer	0.00376	0.00381	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—LPAR1—prostate cancer	0.0037	0.00374	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GRP—prostate cancer	0.0037	0.00374	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PLCB2—prostate cancer	0.00366	0.0037	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GNG5—prostate cancer	0.00366	0.0037	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GRPR—prostate cancer	0.00362	0.00366	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CX3CL1—prostate cancer	0.00359	0.00363	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL17RD—prostate cancer	0.0035	0.00354	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PDE4D—prostate cancer	0.00349	0.00353	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GNG5—prostate cancer	0.00332	0.00336	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PTHLH—prostate cancer	0.00318	0.00322	CbGpPWpGaD
Cinalukast—CYSLTR1—bone marrow—prostate cancer	0.00316	0.281	CbGeAlD
Cinalukast—CYSLTR1—Signaling Pathways—JUP—prostate cancer	0.00312	0.00315	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—WNT4—prostate cancer	0.00312	0.00315	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—ANXA1—prostate cancer	0.00299	0.00303	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MC2R—prostate cancer	0.00297	0.00301	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RALBP1—prostate cancer	0.00297	0.00301	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PTHLH—prostate cancer	0.00289	0.00292	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PRKACB—prostate cancer	0.00283	0.00286	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CALCA—prostate cancer	0.0028	0.00284	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PPP3CA—prostate cancer	0.00276	0.00279	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL12—prostate cancer	0.00274	0.00277	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—ANXA1—prostate cancer	0.00272	0.00275	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PENK—prostate cancer	0.00265	0.00268	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.00264	0.00267	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.0026	0.00263	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CALCA—prostate cancer	0.00255	0.00257	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GHR—prostate cancer	0.00253	0.00256	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.00253	0.00255	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PRKCQ—prostate cancer	0.0025	0.00253	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL12—prostate cancer	0.00249	0.00252	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.00246	0.00249	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NRP1—prostate cancer	0.00242	0.00245	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—ADRB2—prostate cancer	0.00235	0.00238	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—VAV3—prostate cancer	0.00229	0.00232	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PRKCQ—prostate cancer	0.00227	0.0023	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.00226	0.00228	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VIP—prostate cancer	0.00225	0.00228	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GNRH1—prostate cancer	0.00225	0.00228	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—ITPR1—prostate cancer	0.00222	0.00225	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LPAR1—prostate cancer	0.00218	0.00221	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GRP—prostate cancer	0.00218	0.00221	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLCB2—prostate cancer	0.00216	0.00219	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LRP2—prostate cancer	0.00216	0.00219	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—ADRB2—prostate cancer	0.00213	0.00216	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—P4HB—prostate cancer	0.00212	0.00214	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CX3CL1—prostate cancer	0.00212	0.00214	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—VAV3—prostate cancer	0.00208	0.0021	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIST1H2BG—prostate cancer	0.00208	0.0021	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDE4D—prostate cancer	0.00206	0.00209	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GRB7—prostate cancer	0.00206	0.00209	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—ITPR1—prostate cancer	0.00202	0.00204	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIST1H4H—prostate cancer	0.00201	0.00203	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL8—prostate cancer	0.00201	0.00203	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.002	0.00202	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GNG5—prostate cancer	0.00196	0.00198	CbGpPWpGaD
Cinalukast—CYSLTR1—lymph node—prostate cancer	0.00196	0.174	CbGeAlD
Cinalukast—CYSLTR1—Signaling Pathways—PTHLH—prostate cancer	0.00171	0.00173	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TGFBR1—prostate cancer	0.00171	0.00173	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKR1C3—prostate cancer	0.00168	0.0017	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRKACB—prostate cancer	0.00167	0.00169	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—THBS1—prostate cancer	0.00163	0.00165	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PPP3CA—prostate cancer	0.00163	0.00165	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ANXA1—prostate cancer	0.00161	0.00162	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRKCZ—prostate cancer	0.00158	0.00159	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CG—prostate cancer	0.00154	0.00156	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PARP1—prostate cancer	0.00152	0.00154	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGFR4—prostate cancer	0.00152	0.00154	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CALCA—prostate cancer	0.0015	0.00152	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL12—prostate cancer	0.00147	0.00149	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CG—prostate cancer	0.0014	0.00142	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CASP9—prostate cancer	0.00138	0.0014	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CD—prostate cancer	0.00135	0.00137	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRKCQ—prostate cancer	0.00134	0.00136	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NGFR—prostate cancer	0.00134	0.00136	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAP3K7—prostate cancer	0.00132	0.00134	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF10—prostate cancer	0.00127	0.00129	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ADRB2—prostate cancer	0.00126	0.00127	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—JAK2—prostate cancer	0.00124	0.00126	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAP2K1—prostate cancer	0.00124	0.00125	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CD—prostate cancer	0.00123	0.00124	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VAV3—prostate cancer	0.00123	0.00124	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TGFBR2—prostate cancer	0.00121	0.00123	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ITPR1—prostate cancer	0.00119	0.00121	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CB—prostate cancer	0.00118	0.00119	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF1R—prostate cancer	0.00114	0.00115	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL8—prostate cancer	0.00113	0.00115	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—JAK2—prostate cancer	0.00113	0.00114	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LPL—prostate cancer	0.00109	0.00111	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—IL2—prostate cancer	0.00108	0.0011	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDGFRB—prostate cancer	0.00108	0.0011	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CB—prostate cancer	0.00107	0.00108	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ITGB3—prostate cancer	0.00106	0.00107	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL8—prostate cancer	0.00103	0.00104	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB3—prostate cancer	0.00102	0.00104	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGFR2—prostate cancer	0.00102	0.00103	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL2—prostate cancer	0.000985	0.000996	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TERT—prostate cancer	0.000981	0.000992	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIF1A—prostate cancer	0.000938	0.000949	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LEP—prostate cancer	0.000916	0.000926	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CAV1—prostate cancer	0.000908	0.000918	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KDR—prostate cancer	0.000897	0.000908	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ESR1—prostate cancer	0.000874	0.000884	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BAD—prostate cancer	0.000854	0.000863	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APC—prostate cancer	0.000827	0.000836	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CG—prostate cancer	0.000827	0.000836	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IRS1—prostate cancer	0.000817	0.000826	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EGF—prostate cancer	0.000817	0.000826	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GSK3B—prostate cancer	0.000793	0.000802	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—INS—prostate cancer	0.000783	0.000791	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CREBBP—prostate cancer	0.000766	0.000775	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF1—prostate cancer	0.000757	0.000766	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EGFR—prostate cancer	0.000753	0.000762	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAP2K1—prostate cancer	0.000732	0.00074	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CD—prostate cancer	0.000727	0.000735	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CA—prostate cancer	0.00072	0.000728	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SERPINE1—prostate cancer	0.000719	0.000727	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—KRAS—prostate cancer	0.000711	0.00072	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF2—prostate cancer	0.000696	0.000704	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOS3—prostate cancer	0.000686	0.000694	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—JAK2—prostate cancer	0.000667	0.000675	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CA—prostate cancer	0.000654	0.000661	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MDM2—prostate cancer	0.000651	0.000658	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB2—prostate cancer	0.000642	0.000649	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CB—prostate cancer	0.000633	0.000641	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL8—prostate cancer	0.000609	0.000616	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN1B—prostate cancer	0.000594	0.000601	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AKT1—prostate cancer	0.000588	0.000595	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CASP3—prostate cancer	0.000583	0.000589	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL2—prostate cancer	0.000582	0.000588	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL6—prostate cancer	0.000579	0.000585	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCND1—prostate cancer	0.000567	0.000574	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CTNNB1—prostate cancer	0.000562	0.000568	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MMP9—prostate cancer	0.000551	0.000557	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN1A—prostate cancer	0.000549	0.000555	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PTEN—prostate cancer	0.000547	0.000554	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AKT1—prostate cancer	0.000534	0.00054	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EP300—prostate cancer	0.000522	0.000528	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SRC—prostate cancer	0.000508	0.000513	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VEGFA—prostate cancer	0.000494	0.0005	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STAT3—prostate cancer	0.00049	0.000495	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MYC—prostate cancer	0.000455	0.00046	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TGFB1—prostate cancer	0.000454	0.000459	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EGFR—prostate cancer	0.000445	0.00045	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KRAS—prostate cancer	0.00042	0.000425	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CA—prostate cancer	0.000386	0.000391	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TP53—prostate cancer	0.000374	0.000378	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL6—prostate cancer	0.000342	0.000346	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKT1—prostate cancer	0.000315	0.000319	CbGpPWpGaD
